GlassScriptPhysician profile
Mohammed Taleb
NPI 1285899633
$17,968.72
in general payments reported to CMS, 2019-2025
52 companies · $4,082 in 2025
The $4,082 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,345 · 2020: $683 · 2021: $1,241 · 2022: $2,103 · 2023: $4,027 · 2024: $4,488 · 2025: $4,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,243 · Travel and Lodging: $5,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,243.44 |
| Travel and Lodging | $5,352.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,475.70 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Launcher |
| Edwards Lifesciences Corporation | $2,841.07 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,209.96 | 2023-2025 | Triclip, Mitraclip, Amplatzer Amulet |
| Boston Scientific Corporation | $823.96 | 2021-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Astrazeneca Pharmaceuticals LP | $817.73 | 2019-2025 | Farxiga, Wainua, Airsupra |
| Amgen INC. | $692.82 | 2019-2025 | Repatha, Tezspire |
| Janssen Pharmaceuticals, INC | $665.31 | 2019-2024 | Xarelto |
| Pfizer INC. | $543.23 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $541.95 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $526.78 | 2021-2025 | Jardiance |
| Atricure, INC. | $437.57 | 2023-2025 | Synergy Ablation System |
| Kestra Medical Technology Services, INC. | $416.42 | 2023-2024 | Assure Wcd |
| Shockwave Medical, INC | $333.00 | 2022 | |
| Amarin Pharma, INC. | $299.22 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $281.71 | 2022-2025 | Eliquis, Camzyos |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $263.84 | 2020-2022 | |
| Medical Device Business Services, INC. | $230.83 | 2024 | Carto 3 |
| Merck Sharp & Dohme LLC | $220.58 | 2021-2023 | Verquvo |
| Scpharmaceuticals INC. | $210.97 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $204.36 | 2019-2022 | |
| Medtronic Vascular, INC. | $196.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $136.67 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.72 | 2019-2025 | Glassia |
| Lexicon Pharmaceuticals, INC. | $121.73 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $114.24 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals International, Plc | $101.98 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $100.49 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.94 | 2019-2022 | |
| Bridgebio Pharma, INC. | $76.48 | 2025 | Attruby |
| Novo Nordisk INC | $72.82 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $72.05 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Kiniksa Pharmaceuticals, LTD. | $65.11 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $60.45 | 2022-2025 | Onpattro |
| Philips North America LLC | $56.83 | 2024-2025 | (Ak6) Vest Therapy, Ice 3d |
| Balt USA, LLC | $53.63 | 2024 | Optima Coil System |
| Actelion Pharmaceuticals US, INC. | $51.78 | 2023 | Uptravi, Opsumit |
| Cardiva Medical, INC. | $42.77 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Inspire Medical Systems, INC. | $42.00 | 2025 | Inspire |
| Abiomed | $41.52 | 2025 | |
| United Therapeutics Corporation | $38.92 | 2023-2024 | Tyvaso |
| Angiodynamics, INC. | $36.65 | 2024 | Angiovac |
| Baxter Healthcare | $31.30 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $26.59 | 2019 | |
| Verona Pharma, INC. | $25.85 | 2025 | Ohtuvayre |
| Abbvie INC. | $24.10 | 2022 | |
| Cvrx, INC. | $23.72 | 2024 | Barostim Neo System |
| Chiesi USA, INC. | $23.61 | 2019 | |
| Terumo Medical Corporation | $18.00 | 2023 | Angio-Seal, Metacross Otw |
| Biosense Webster, INC. | $17.40 | 2025 | Octaray Mapping Catheter |
| Cardiovascular Systems INC. | $17.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.07 | 2020 | |
| Irhythm Technologies, INC. | $14.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Taleb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.